Classification of pancreatic cystic lesions using SELDI-TOF mass spectrometry

ANZ Journal of Surgery

Volumn 77, Issue 8, 2007, Pages 648-653

  Scarlett, Christopher J ^a   Samra, Jaswinder S ^a   Xue, Aiqun ^a   Baxter, Robert C ^b   Smith, Ross C ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cyst fluid; Pancreatic cancer; Proteomics; SELDI TOF

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYST FLUID; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FEMALE; HUMAN; MALE; PANCREAS ADENOCARCINOMA; PANCREAS CYST; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADENOCARCINOMA; FEMALE; HUMANS; MALE; PANCREATIC CYST; PANCREATIC NEOPLASMS; PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 34447333697     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2007.04179.x     Document Type: Article

References (49)

1. Brugge WR, Lauwers GY, Sahani D et al. Cystic neoplasms of the pancreas. N. Engl. J. Med. 2004 351 : 1218 26.
2. Pelaez-Luna M, Chari ST. Cyst fluid analysis to diagnose pancreatic cystic lesions: an as yet unfulfilled promise. Gastroenterology 2006 130 : 1007 9 discussion 1009.
3. van der Waaij LA, van Dullemen HM, Porte RJ. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest. Endosc. 2005 62 : 383 9.
4. Zamboni G, Kloppel G, Hruban R. Mucinous cystic neoplasms of the pancreas. In : Hamilton SR, Aaltonen LA (eds). Pathology and Genetics of Tumours of the Digestive System. Lyon : IARC Press, 2000 234 6.
5. Brugge WR, Lewandrowski K, Lee-Lewandrowski E et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004 126 : 1330 36.
6. Centeno BA, Lewandrowski KB, Warshaw AL et al. Cyst fluid cytologic analysis in the differential diagnosis of pancreatic cystic lesions. Am. J. Clin. Pathol. 1994 101 : 483 7.
7. Curry CA, Eng J, Horton KM et al. CT of primary cystic pancreatic neoplasms: can CT be used for patient triage and treatment? AJR Am. J. Roentgenol. 2000 175 : 99 103.
8. Ahmad NA, Kochman ML, Brensinger C et al. Interobserver agreement among endosonographers for the diagnosis of neoplastic versus non-neoplastic pancreatic cystic lesions. Gastrointest. Endosc. 2003 58 : 59 64.
9. Brugge WR. Should all pancreatic cystic lesions be resected? Cyst-fluid analysis in the differential diagnosis of pancreatic cystic lesions: a meta-analysis. Gastrointest. Endosc. 2005 62 : 390 91.
10. Centeno BA, Warshaw AL, Mayo-Smith W et al. Cytologic diagnosis of pancreatic cystic lesions. A prospective study of 28 percutaneous aspirates. Acta Cytol. 1997 41 : 972 80.
11. Lewandrowski KB, Southern JF, Pins MR et al. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma. Ann. Surg. 1993 217 : 41 7.
12. Hammel P, Levy P, Voitot H et al. Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas. Gastroenterology 1995 108 : 1230 35.
13. Scarlett CJ, Smith RC, Saxby A et al. Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology. Gastroenterology 2006 130 : 1670 78.
14. Scarlett CJ, Saxby AJ, Nielsen A et al. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture. Hepatology 2006 44 : 658 66.
15. Petricoin EF, Ardekani AM, Hitt BA et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002 359 : 572 7.
16. Koopmann J, Zhang Z, White N et al. Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin. Cancer Res. 2004 10 : 860 68.
17. Kozak KR, Amneus MW, Pusey SM et al. Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis. Proc. Natl. Acad. Sci. U S A 2003 100 : 12343 8.
18. Wadsworth JT, Somers KD, Cazares LH et al. Serum protein profiles to identify head and neck cancer. Clin. Cancer Res. 2004 10 : 1625 32.
19. Li J, Zhang Z, Rosenzweig J et al. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem. 2002 48 : 1296 304.
20. Khalid A, Finkelstein S, McGrath K. Molecular diagnosis of solid and cystic lesions of the pancreas. Clin. Lab. Med. 2005 25 : 101 16.
21. Song MH, Lee SK, Kim MH et al. EUS in the evaluation of pancreatic cystic lesions. Gastrointest. Endosc. 2003 57 : 891 6.
22. Sedlack R, Affi A, Vazquez-Sequeiros E et al. Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointest. Endosc. 2002 56 : 543 7.
23. Le Borgne J, de Calan L, Partensky C. Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association. Ann. Surg. 1999 230 : 152 61.
24. Johnson CD, Stephens DH, Charboneau JW et al. Cystic pancreatic tumors: CT and sonographic assessment. AJR Am. J. Roentgenol. 1988 151 : 1133 8.
25. Ahmad NA, Kochman ML, Lewis JD, Ginsberg GG. Can EUS alone differentiate between malignant and benign cystic lesions of the pancreas? Am. J. Gastroenterol. 2001 96 : 3295 300.
26. O'Toole D, Palazzo L, Hammel P et al. Macrocystic pancreatic cystadenoma: the role of EUS and cyst fluid analysis in distinguishing mucinous and serous lesions. Gastrointest. Endosc. 2004 59 : 823 9.
27. Hastings PR, Nance FC, Becker WF. Changing patterns in the management of pancreatic pseudocysts. Ann. Surg. 1975 181 : 546 51.
28. Kloppel G, Kosmahl M. Cystic lesions and neoplasms of the pancreas. The features are becoming clearer. Pancreatology 2001 1 : 648 55.
29. Fernandez-del Castillo C, Targarona J, Thayer SP et al. Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch. Surg. 2003 138 : 427 3 discussion 433-4.
30. Tada M, Kawabe T, Arizumi M et al. Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients. Clin. Gastroenterol. Hepatol. 2006 4 : 1265 70.
31. Frossard JL, Amouyal P, Amouyal G et al. Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions. Am. J. Gastroenterol. 2003 98 : 1516 24.
32. Hammel P, Voitot H, Vilgrain V et al. Diagnostic value of CA 72-4 and carcinoembryonic antigen determination in the fluid of pancreatic cystic lesions. Eur. J. Gastroenterol. Hepatol. 1998 10 : 345 8.
33. Pinto MM, Meriano FV. Diagnosis of cystic pancreatic lesions by cytologic examination and carcinoembryonic antigen and amylase assays of cyst contents. Acta Cytol. 1991 35 : 456 63.
34. Sand JA, Hyoty MK, Mattila J et al. Clinical assessment compared with cyst fluid analysis in the differential diagnosis of cystic lesions in the pancreas. Surgery 1996 119 : 275 80.
35. Sperti C, Pasquali C, Guolo P et al. Evaluation of cyst fluid analysis in the diagnosis of pancreatic cysts. Ital. J. Gastroenterol. 1995 27 : 479 83.
36. Tatsuta M, Iishi H, Ichii M et al. Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas. Cancer 1986 57 : 1836 9.
37. Z'Graggen K, Rivera JA, Compton CC et al. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann. Surg. 1997 226 : 491 8 discussion 498-500.
38. Almoguera C, Shibata D, Forrester K et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988 53 : 549 54.
39. Hoshi T, Imai M, Ogawa K. Frequent K-ras mutations and absence of p53 mutations in mucin-producing tumors of the pancreas. J. Surg. Oncol. 1994 55 : 84 91.
40. Tada M, Yokosuka O, Omata M et al. Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing. Cancer 1990 66 : 930 35.
41. Tada M, Omata M, Ohto M. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma. Gastroenterology 1991 100 : 233 8.
42. Tada M, Omata M, Ohto M. Ras gene mutations in intraductal papillary neoplasms of the pancreas. Analysis in five cases. Cancer 1991 67 : 634 7.
43. Bartsch D, Bastian D, Barth P et al. K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas. Ann. Surg. 1998 228 : 79 86.
44. Jimenez RE, Warshaw AL, Z'Graggen K et al. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy. Ann. Surg. 1999 230 : 501 9 discussion 509-11.
45. Khalid A, McGrath KM, Zahid M et al. The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology. Clin. Gastroenterol. Hepatol. 2005 3 : 967 73.
46. Inagaki M, Maguchi M, Kino S et al. Mucin-producing tumors of the pancreas: clinicopathological features, surgical treatment, and outcome. J. Hepatobiliary Pancreat. Surg. 1999 6 : 281 5.
47. D'Angelica M, Brennan MF, Suriawinata AA et al. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann. Surg. 2004 239 : 400 408.
48. Cuillerier E, Cellier C, Palazzo L et al. Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas. Am. J. Gastroenterol. 2000 95 : 441 5.
49. Adsay NV, Pierson C, Sarkar F et al. Colloid (mucinous noncystic) carcinoma of the pancreas. Am. J. Surg. Pathol. 2001 25 : 26 42.